DocSym
β
Searchsearch
Search
(Y43.4) Immunosuppressive agents
More details coming soon
74 096 in individuals diagnosis immunosuppressive agents confirmed
2 382 deaths with diagnosis immunosuppressive agents
3% mortality rate associated with the disease immunosuppressive agents
Diagnosis immunosuppressive agents is diagnosed Women are 33.74% more likely than Men
24 547
Men receive the diagnosis immunosuppressive agents
789 (3.2 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
49 549
Women receive the diagnosis immunosuppressive agents
1 593 (3.2 %)Died from this diagnosis.
Risk Group for the Disease immunosuppressive agents - Men aged 65-69 and Women aged 60-64
In Men diagnosis is most often set at age 0-14, 20-29, 35-39, 45-74, 80-84
Less common in men the disease occurs at Age 0-1, 15-19, 30-34, 40-44, 75-79, 85-95+Less common in women the disease occurs at Age 0-5, 25-29, 35-39, 90-95+
In Women diagnosis is most often set at age 5-24, 30-34, 40-89
Disease Features immunosuppressive agents
Absence or low individual and public risk
Immunosuppressive agents - what does this mean
Immunosuppressive agents are drugs that are used to suppress the immune system's response. these agents work by blocking the body's ability to produce antibodies and other components of the immune system that are involved in fighting infection and disease. they can be used to prevent organ rejection after a transplant, to treat autoimmune diseases such as rheumatoid arthritis, and to treat certain types of cancer.
What happens during the disease - immunosuppressive agents
Immunosuppressive agents are drugs that suppress the immune system and prevent it from attacking the body. they work by blocking the activity of certain immune cells, such as t-cells and b-cells, which are responsible for initiating and sustaining an immune response. by blocking these cells, the agents can reduce inflammation, prevent organ rejection, and reduce the risk of autoimmune diseases. however, long-term use of immunosuppressive agents can lead to an increased risk of infection, cancer, and other serious complications.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical examination
- Blood tests
- Urine tests
- Imaging studies, such as X-rays, CT scans, or MRIs
- Tissue biopsy
- Bone marrow biopsy
- Immunological tests
Treatment and Medical Assistance
Main goal of the treatment: To reduce the activity of the immune system
- Prescribe immunosuppressive agents
- Monitor patient's response to therapy
- Adjust the dosage of the medication as needed
- Administer other medications to reduce inflammation or manage side effects
- Provide patient education on the potential risks and benefits of immunosuppressive agents
- Monitor the patient's vital signs
- Monitor the patient's laboratory tests for signs of infection or other adverse reactions
- Encourage the patient to report any symptoms of infection or other adverse reactions
12 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Immunosuppressive agents - Prevention
Immunosuppressive agents can be prevented by avoiding contact with people who have active infections, getting vaccinated, and practicing good hygiene. additionally, individuals should be aware of any changes in their health and seek medical advice immediately if they experience any unusual symptoms.